According to the Investigation of Defensive Medicine in Massachusetts, the estimated costs of defensive medicine are around $1.4 billion a year. The study also reported that an average of 18-28 percent of tests, referrals, procedures and consultations and around 13 percent of hospitalizations were ordered due to defensive reasons.
The study consisted of about 900 physicians in Massachusetts and was conducted between Nov. 2007 and Apr. 2008.
Read the UConn Advance’s report on the defensive medicine study.
Read the results of the Investigation of Defensive Medicine in Massachusetts (pdf).
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
